Clinical Trials Directory

Trials / Completed

CompletedNCT03824977

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSix minutes stepper test (6MST)The 6MST is done using a stepper (Stepper essential, Decathlon(TM), France), with a walking height of 20 cm, placed in front of a wall or parallel bars, so patients can hold on if necessary. Patients are instructed to make the maximum number of steps possible in 6 minutes, and are given a time check at one minute intervals.
DIAGNOSTIC_TESTSit to stand test (STST)The STST is done using a chair measuring 47 cm in height. The patient are instructed to sit in the chair and then to do the maximum number of lifts possible from the chair, in 1 minute, with arms folded and without leaning against the chair.

Timeline

Start date
2018-11-21
Primary completion
2020-02-04
Completion
2020-02-04
First posted
2019-01-31
Last updated
2022-03-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03824977. Inclusion in this directory is not an endorsement.

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery (NCT03824977) · Clinical Trials Directory